News

Rejuven Awarded “High Technology Expertise”

Rejuven continues to research biological drugs supported by Torch Program and has developed its core independent intellectual property rights in recent years. On December 16, 2021, Rejuven Dermaceutial was awarded “High Technology Expertise” in the first nominated high-tech enterprises list.

 

9fbd3bfb4747dc3544919c6ba0d9598.png

Copyright © 2019 Hangzhou Rejuven Dermaceutical Co., Ltd. All Rights Reserved Zhejiang Public Network Security No. 330108020005711备案号:浙ICP备15013641号